B2 adrenergic receptor (ADRB2) gene variation could explain differences in bronchodilator response among patients with asthma or identify a subgroup of patients with reduced response.
The aim of our research was identified polymorphisms in the ADRB2 gene in Russian asthma pediatric patients (in Perm region). 44 children from 3 to 18 years of age with bronchial asthma were examined. Mild asthma was in 95,5%, moderate asthmain 4,5%. Gly16Arg and Gln27Glu mutations of ADRB2 gene were identified by PCR technique.
Results
Gly16Arg mutations of ADRB2 gene was identified in 45,5% and Gln27Glu mutationsin 27,2% (table 1) .
There were not correlations between severity of bronchial asthma and ADRB2 gene polymorphisms (Gly16Arg and Gln27Glu mutations). The total IgE level was increased in group with Gly16Arg mutation 565,6±242,6 ME/ml, comparatively group without mutation (255±60,31 ME/ml, p=0,563). We found that asthma exacerbations in children with gene mutations occurs after allergen's exposure in 64% cases. In group without the mutation asthma exacerbations occurs in acute viral respiratory infections in 68% cases.
Thus ADRB2 gene polymorphisms may be associated with clinical features of asthma in children. 
Submit your next manuscript to BioMed

